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The role of protein kinase C @‘KC) in cellular regulation of L-type Car’ channels was investigated in human umbilical vein smooth muscle. 
Activation of PKC, by low concentrations (< 30 nM) of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) caused inhibition of Ca*’ channels, while higher 
concentrations of TPA (>lOO nM) elicited a transient rise, followed by sustained inhibition of Ca*’ channel activity in cell-attached patches. Low 
TPA concentrations predominantly reduced channel availability, while high concentrations of TPA (100 nM) transiently increased channel availability 
and, in addition, prolonged mean open time. The inactive 4-a-phorbol-12,13didecanoate failed to affect channel activity, and pretreatment of the 
cells with PKC inhibitors (H-7, chelerythrine) antagonized inhibitory and stimulatory effects of TPA. Our results provide evidence for two distinct 
PKC-dependent mechanisms of L-type Ca*’ channel regulation in smooth muscle. 
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1. Introduction 
Calcium- and phospholipid-dependent protein kinase 
(PKC) has been suggested to play a critical role in 
smooth muscle Ca” homeostasis and regulation of con- 
tractility [1,2]. Among the various membrane transport 
systems which serve Ca 2+ homeostasis, voltage-depend- 
ent Ca” channels have been implicated as one likely 
target of PKC regulation. Measurements of 45Ca2+ influx 
and membrane currents in a variety of tissues, including 
also smooth muscle, have provided substantial evidence 
for PKC-dependent modulation of L-type channels [3- 
8]. However, the relationship between cellular PKC ac- 
tivity and voltage-dependent Ca2+ entry in smooth mus- 
cle is still a matter of controversy. The use of tumor 
promoting phorbol ester as experimental tool to activate 
PKC in smooth muscle has yielded divergent results, 
providing evidence for both phorbolester-induced facili- 
tation [3,5] as well as inhibition of voltage-dependent 
Ca” entry [4,9]. Although contrasting in nature, the 
available evidence unequivocally demonstrate PKC-de- 
pendent regulation of smooth muscle L-type Ca” chan- 
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Abbreviations: EGTA, ethylene glycol bis (B-aminoethyl ether) 
N,N,W,N-tetraacetic acid; H-7, I-(5-isoquinolinylsulfonyl)-2-methyl- 
piperaxine; HEPES, iV-2-hydroxyethylpiperaxine-W-ethane-sulfonic 
acid; P,,, channel’s probability of being in the open state; PKC, protein 
kinase C; PDD, 4-a-phorbol-12,13_didecanoate; TEA-Cl, tetraethyl- 
ammonium chloride; TPA, 12-O-tetradecanoyl-phorbol-13-acetate. 
nels as a central albeit complex mechanism which links 
signal input from a variety of hormone receptors to Ca2+ 
entry. Thus, PKC may be of particular importance for 
fine adjustment of Ca2+ channel activity by hormones 
and neurotransmitter. Until now, PKC-dependent mod- 
ulation of single smooth muscle Ca2+ channels in intact 
cells has not been investigated. In this study we have 
analyzed changes in L-type Ca2’ channel function, in- 
duced by phorbol ester in intact smooth muscle cells 
isolated from human umbilical vein, and present evi- 
dence for a dual PKC-dependent channel regulation. 
2. Materials and methods 
2.1. Cell preparation 
Single smooth muscle cells were enzymatically isolated from the 
media of human umbilical veins. Vessels were cannulated, and perfused 
with HEPES buffered saline solution, containing (in mM): 137 NaCl, 
5.4 KCl, 2 CaCl,, 15 HEPES. Endothelial cells were removed using 
dispase (Boehringer Mannheim, type II) as described previously [lo]. 
Subsequently, disaggregation of smooth muscle tissue was achieved by 
tilling the vessels with low Ca*’ (0.1 mM) Hanks buffer (Sera Lab Ltd.) 
which was supplemented with 0.5 mg/ml collagenase (Worthington, 
type II), 0.5 mg/ml trypsin inhibitor (Worthington) and 1 mg/ml fatty 
acid-free bovine serum albumin. Vessels tilled with collagenase contain- 
ing Hanks solution, were incubated for 10 min at 37 “C. Thereafter the 
Hanks buffer which now contained single, mostly relaxed, elongated 
smooth muscle cells, was collected, centrifuged (5 min; 250 x g), and the 
cells were resuspended and stored in a solution containing [mM]: 110 
K’ aspartate, 20 KCl, 2 MgCl,, 20 HEPES, 2 EGTA @Ca = 7, see 
below) at 4”C, and used for experimentation within 36 hours. 
2.2. Current measurements 
Ba*’ currents through single Ca*’ channels were recorded in cell- 
attached patches of membrane. In order to establish constant cell po- 
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tentials of approximately 0mV, we used a high K+ low Cl- extracellular 
solution which contained [mM]: 110 K’ aspartate, 20 KCl, 2 MgCl,, 
20 HEPES, 2 EGTA, pH was adjusted to 7.4 with N-methyl-n-glucam- 
ine, and pCa was adjusted according to Robertson and Potter [l 11. The 
pipette solution contained [mMJ: 80 BaCl,, 30 TEA-Cl and 15 HEPES, 
pH adjusted to 7.4. Patch pipettes were fabricated from borosilicate 
glass (Clark Electromedical Instruments; Pangboume UK), and had 
resistances of 5-10 MR. Experiments were performed at room temper- 
ature. Since basal channel activity was usually low, which impeded 
quantification of effects, the dihydropyridine-Ca2+ channel activator 
S(-)-BayK 8644 (0.5 PM) was added to the pipette solution in most 
experiments. For voltage clamp and current amplification, aList EPC/7 
patch-clamp amplifier (List, Darmstadt, Germany) was used. Current 
records were stored on video tape using a VRlO digital data recorder 
(Instrutech Corporation, Mineola, USA). Records were played back, 
filtered at 1 kHz (-3dB) and digitized at a rate of 5 kHz. Data were 
analyzed with pClamp (Axon Instruments, Foster City, CA, USA) and 
Transit (BCM, Houston, TX, USA) software. Channel actvity in mul- 
tichannel patches was calculated as the mean number of channels which 
opened during depolarizing voltage steps. The availability of a channel 
to open upon depolarization was quantified as the proportion of sweeps 
which showed at least one opening (active sweeps), according to the 
applied criteria of level detection (Transit software). Averaged data are 
presented as mean f S.E.M. 
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2.3. Chemicals 
Collagenase, type CLS II and soybean trypsin inhibitor type were 
obtained from Worthington Biochemical Corporation (Freehold, NJ, 
USA); dispase type II was from Boehringer (Mannheim, Germany); 
fatty acid-free bovine serum albumin from Behring (Marburg, Ger- 
many); Hanks balanced salt solution was from Sera Lab Ltd. (Sussex, 
UK); Chelerythrine was from LC Services Corp. (Wobum, MA, USA); 
S(-)-BayK 8644 and H-7 1-(5-isoquinolinylsulfonyl)-2-methyl- 
piperazine were purchased from Research Biochemicals Incorporated 
(Natic, MA, USA); TPA, PDD, and all other chemicals from Sigma 
Chemical Co. (Deisenhofen, Germany). 
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3. Results 
3.1. TPA exerts a dual modulatory effect on smooth 
muscle Cd’ channels 
Using 80 mM Ba” as charge carrying cation, L-type 
Ca” channels in cell-attached patches of human umbili- 
cal vein exhibited a unitary conductance of approxi- 
mately 21 pS (20.6 f 0.5, n = 17) and typical voltage 
dependence showing a threshold of activation above -30 
mV. Time courses of channel activity in cell-attached 
patches were monitored by depolarizing the patches of 
membrane very 5 s to 0 mV from a holding potential of 
-70 mV (referring to the cytoplasmic side). Exposure of 
the cells to TPA in concentrations up to 30 nM reduced 
channel activity in cell-attached patches within l-3 min. 
A representative xperiment demonstrating inhibition of 
channel activity by 10 nM TPA is illustrated in Fig. 1A. 
In contrast, one order of magnitude higher TPA concen- 
trations (100 nM) induced a marked but transient in- 
crease of channel activity which was followed by sus- 
tained channel inhibition (Fig. 1B). These effects of TPA 
were observed in the presence and absence of 0.5 ,uM 
S(-)-BayK 8644 (included in the pipette solution) as 
well. Fig. 1C illustrates the effects of cumulative admin- 
istration of TPA on channel activity recorded in the 
absence of S(-)-BayK 8644. When the TPA concentra- 
tion was sequentially increased in the bath solution, L- 
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Fig. 1. Effects of phorbol ester on L-type Ca*’ channel activity in 
cell-attached patches. Depolarizing voltage steps (test potential = 0 
mV, holding potential = -70 mV) were applied every 5 s and channel 
activity during individual steps is expressed as mean number of open 
channels. (A) Time course of channel activity during extracellular ad- 
ministration of 10 nM TPA. (B) Effect of 100 nM TPA. (C) Effects of 
sequential administration of 10 and 100 nM TPA. (D) Sequential ad- 
ministration of 10 and 100 nM PDD. Experiments illustrated in A,B 
and D were performed in the presence of 0.5 PM S(-)-BayK 8644 
(included in the pipette solution). 
type channels in cell-attached patches were first inhibited 
at 10 nM and subsequently stimulated at 100 nM. Fig. 
1D shows an experiment in which the inactive 4-c+phor- 
bol-12,13-didecanoate (PDD) was used instead of TPA. 
PDD neither inhibited nor stimulated L-type Ca2’ chan- 
nel activity (n = 3). Fig. 2 shows the stimulatory effect of 
100 nM TPA on channel activity recorded during depo- 
larizing voltage ramps. TPA did not affect single channel 
conductance but apparently increased the number of 
channels which opend upon depolarization. During this 
transient stimulatory effect, voltage-dependence of acti- 
vation was shifted to more negative potentials, as evident 
from the average current derived from 32 current re- 
sponses to depolarizing voltage ramps (Fig. 2, lower 
panel). Fig. 3 summarizes the observed TPA-induced 
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modulation of channel activity, and in addition shows 
the effects of the PKC inhibitor H-7. Pretreatment of the 
cells with H-7 (10 ,uM for 5 min) which by itself slightly 
enhanced channel activity, abolished the inhibitory effect 
of 10 nM TPA and clearly suppressed the transient stim- 
ulatory effect of 100 nM TPA (n = 4). Consistantly, a 
similar result was obtained with the selective PKC inhib- 
itor chelerythrine (1 PM, n = 2, not shown). 
3.2. TPA affects channel availability and open time 
distribution 
Experiments with patches of membrane containing a 
single L-type Ca** channel were analyzed for TPA-in- 
duced changes in channel availability and open time dis- 
tribution. Fig. 4 illustrates an experiment in which no 
overlapping events were detected, indicating the presence 
of only one channel. At 10 nM TPA, the probability of 
the channel being in the open state (P,,) decreased from 
27 to 16% (calculated from 25 and 30 voltage steps to 0 
mV in the absence and presence of TPA respectively; Fig. 
4 middle panel). This reduction of P,, was associated with 
a reduction of the channel’s availability to open upon 
depolarization, i.e. the fraction of depolarizing voltage 
steps which exhibited channel activity (active sweeps; 
AS, Fig. 4, middle panel). In the presence of BayK 8644 
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Fig. 2. Effect of TPA (100 nM) on current to voltage relationship. 
Channel activity was recorded during depolarizing voltage ramps (from 
-80 to +60 mV, 0.1 mV/ms, holding potential = -70 mv). Upper panel 
illustrates representative individual current responses recorded in the 
absence and presence of TPA. Leak current has been subtracted and 
zero current level is indicated by arrows and dashed lines. Lower panel 
shows the average currents obtained from 32 and 16 sweeps in the 
absence and presence of TPA respectively (O.SpM S(-)-BayK 8644 was 
present in the pipette solution). 
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Fig. 3. Effects of TPA on L-type Ca*+ channel activity in the absence 
and presence of H-7. Channel activity was calculated from 30 s record- 
ings (test potential = 0 mV) during the maximum responses (maximum 
deviation from control activity) induced by TPA, and expressed as% 
of control @e-drug value). The effect of 100 nM TPA in the absence 
of H-7 was biphasic and is thus represented by two columns which show 
activity during transient stimulation and sustained inhibition (indicated 
by *, respectively. In all experiments S(-)-BayK 8644 (0.5 PM) was 
present in the pipette solution. Mean values f S.E.M. are shown (n = 
fi). 
(0.5 PM in the pipette solution), two open states 
(GS, = 0.58 _+ 0.14 and rSloW = 9f 1.3ms,n=4)werede- 
tected under control conditions. TPA (10 nM) clearly 
reduced the proportion of long openings (Fig. 4, lower 
panel). Although there was a moderate increase in rSloW, 
changes in open time constants induced by 10 ,uM TPA 
were not statistically significant (q,, = 0.51 f 0.12 and 
r Sl,,W = 14 + 4.5 ms, n = 4; compare with control values 
above). Upon raising the TPA concentration to 100 nM, 
the channel’s PO increased transiently to 53%. Analysis 
of this transient effect of TPA (using 12 sweeps recorded 
during channel activation) showed an increase in the 
fraction of active sweeps (AS) to approximately 90% 
(middle panel) associated with a increase in the propor- 
tion of events which displayed long open times (lower 
panel). Although, analysis of open time distribution was 
impeded by the transient nature of the stimulatory effect 
of TPA, the data derived from current traces recorded 
during transient stimulation indicated that 100 nM TPA 
induced the occurrence of an extremely long lived open 
state (rSloW = 78 ms, mean = 62 + 8 ms, n = 5). These re- 
sults demonstrate a dual effect of TPA on PO of smooth 
muscle L-type Ca*’ channels, which is based on a dual 
effect on channel availability and open time distribution. 
4. Discussion 
A large body of evidence suggests involvement of PKC 
in smooth muscle Ca’+ signalling [2-5,9], but the precise 
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Fig. 4. TPA-induced modulation of open probability, availability and open time distribution of L-type Ca2’ channels. Upper panel illustrates 
representative current traces recorded during depolarizing voltage steps to 0 mV (holding potential = -70 mV) in the absence (control) and presence 
of 10 and 100 nM TPA. Closed state of the channel is indicated by arrows. Middle panel shows open probability (P,,) and availability (given as % 
active sweeps, AS), Lower panel illustrates open time histograms derived from 32 (control, 10 nM TPA) and 12 (100 nM TPA) sweeps. Channel open 
time constants (q,, and r,,,, and probability distribution of corresponding events @) are derived from bi-exponential fit of the data. 
role of this enzyme family in Ca2’ handling by smooth activators are known to be complex in nature, and often 
muscle cells is far from being completely understood. In comprise both fast and slow, long term components of 
this paper we demonstrate that TPA-induced activation action [12]. In cardiac muscle, 200 nM TPA was found 
of endogenous PKC modulates L-type Ca2’ channels of 
human vascular smooth muscle cells in a dual manner. 
to induce a biphasic change in L-type channel activity [6]. 
This finding is in accord with the observed biphasic effect 
Stimulatory and inhibitory effects of TPA were ob- of 100 nM TPA in smooth muscle. For cardiac Ca2’ 
served, depending on the concentration of the phorbol channels, it has been suggested that PKC-dependent 
ester and the time of exposure. Low concentrations of phosphorylation mediates channel activation, and that 
TPA i.e. 10-30 nM which represent approximately the the biphasic response may reflect transient activation of 
ECso value reported for inhibition of dihydropyridine- 
sensitive Ca2’ uptake in A7r5 cells [4] exerted a mono- 
PKC which is followed by sustained down-regulation of 
phasic inhibitory effect, while high concentrations of 
the enzyme. This may as well be taken as an explanation 
of the response observed with high concentrations of 
TPA elicited a biphasic response which consisted of a 
transient stimulatory and a sustained inhibitory compo- 
TPA in smooth muscle. It is however, unlikely that inhi- 
bition of Ca2’ channels by low TPA concentrations is 
nent of action. Biological responses induced by PKC also due to down-regulation of PKC, since (i) the effect 
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was not preceded by an initial stimulatory effect, (ii) 
subsequent application of a IO-fold higher concentration 
of TPA still induced transient channel activation, and 
(iii) the effect was not mimicked by protein kinase C 
inhibitors. TPA-induced stimulation and inhibition of 
smooth muscle L-type channels was antagonized by the 
protein kinase inhibitor H-7 and by chelerythrine which 
appears to be a highly selective inhibitor of PKC [13]. 
Moreover, the actions of TPA were not mimicked by the 
inactive phorbol ester PDD. It appears thus conceivable 
to conclude that the observed effects involve activation 
of PKC as the cellular target of TPA. Channel regulation 
may either involve phosphorylation of proteins consti- 
tuting the Ca*’ channel complex or alternatively phos- 
phorylation of other regulatory proteins within the 
smooth muscle cell. Both the a, and the B subunit of the 
skeletal muscle L-type Ca*‘channel have been demon- 
strated to serve as substrates for PKC in vitro [14,15], 
and reconstituted channels have been shown to be acti- 
vated in response to in vitro phosphorylation [16]. It is 
therefore tempting to speculate about direct phosphoryl- 
ation of channel proteins as the basis of the observed 
effects. The observed dual nature of phorbol ester-in- 
duced channel modulation in smooth muscle suggests the 
involvement of two phosphorylation sites in channel reg- 
ulation. Activation of smooth muscle PKC by low con- 
centrations of TPA resulted in a reduction of channel 
availability and a reduced proportion of long openings, 
while high concentrations increased channel availability 
as well as the proportion of long openings which was in 
addition associated with the occurrence of an extremely 
long lived open state. In vitro phosphorylation of skele- 
tal muscle L-type Ca*+ channels has been reported to 
result mainly in an increase in the proportion of long 
openings associated with a moderate reduction in chan- 
nel availability [16], while activation of PKC in cardiac 
cells has been shown to increase PO of L-type channels 
due to increasing the number of openings during depo- 
larizing pulses rather than mean open time [6]. These 
divergent results obtained in different muscle tissues may 
reflect tissue specific regulation of L-type channels which 
may well be based on tissue specific expression of regula- 
tory proteins and/or PKC isoenzymes [ 12,171. Although, 
the PKC isoenzymes expressed in human umbilical vein 
smooth muscle are as yet unknown, the coexistance of 
multiple PKC isoforms which differ with respect o cellu- 
lar regulation and distribution [18] is likely. Whether 
TPA-induced dual modulation of smooth muscle Ca*+ 
channels involves differential activation of PKC 
isoforms remains to be clarified. Nonetheless, our find- 
ing of a dual phorbol ester-induced Ca*’ channel modu- 
lation in smooth muscle strongly suggests the existence 
of at least two distinct PKC-dependent mechanisms in- 
volving distinct phosphorylation sites at regulatory pro- 
teins. This dual regulation may provide an important 
mechanism responsible for fine tuning L-type Ca*+ chan- 
nel function in smooth muscle. 
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